Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2023 Earnings Call Transcript February 15, 2024 Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-1.82, expectations were $-2.04. Blueprint Medicines Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
LXP Industrial Trust (NYSE:LXP) Q4 2023 Earnings Call Transcript February 15, 2024 LXP Industrial Trust misses on earnings expectations. Reported EPS is $0.04 EPS, expectations were $0.17. LXP Industrial Trust isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you […]
Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Q1 2024 Earnings Call Transcript February 15, 2024 Innovative Solutions and Support, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Innovative Solutions & Support First Quarter Fiscal […]
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript February 14, 2024 Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you […]